Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 2:35 PM
Ignite Modification Date:
2025-12-24 @ 2:35 PM
NCT ID:
NCT00347659
Eligibility Criteria:
Inclusion Criteria:
* Clinical diagnosis of advanced heterogeneous emphysema
* Age \>/= 40
* Clinically significant dyspnea
* Failure of standard medical therapy to relieve symptoms
* Pulmonary function tests with protocol-specified ranges
Exclusion Criteria:
* Alpha-1 protease inhibitor deficiency
* Tobacco use within 16 weeks of initial clinic visit
* Body mass index \< 15 kg/m2 or \> 35 kg/m@
* Clinically significant asthma, chronic bronchitis or bronchiectasis
* Allergy or sensitivity to tetracycline
* Prior lung volume reduction surgery, prior lobectomy or pneumonectomy, prior lung transplantation, prior endobronchial valve placement, prior airway stent placement or prior pleurodesis
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
40 Years
Study:
NCT00347659
Study Brief:
Protocol Section:
NCT00347659